Does FENOFIBRATE Cause Agranulocytosis? 39 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Agranulocytosis have been filed in association with FENOFIBRATE (Fenofibrate). This represents 0.7% of all adverse event reports for FENOFIBRATE.
39
Reports of Agranulocytosis with FENOFIBRATE
0.7%
of all FENOFIBRATE reports
0
Deaths
27
Hospitalizations
How Dangerous Is Agranulocytosis From FENOFIBRATE?
Of the 39 reports, 27 (69.2%) required hospitalization, and 2 (5.1%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FENOFIBRATE. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does FENOFIBRATE Cause?
Myalgia (411)
Dyspnoea (373)
Fatigue (365)
Asthenia (356)
Dizziness (356)
Fall (354)
Drug ineffective (326)
Pruritus (325)
Nausea (311)
Diarrhoea (310)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which FENOFIBRATE Alternatives Have Lower Agranulocytosis Risk?
FENOFIBRATE vs FENOFIBRIC ACID
FENOFIBRATE vs FENOTEROL
FENOFIBRATE vs FENOTEROL HYDROBROMIDE
FENOFIBRATE vs FENOTEROL HYDROBROMIDE\IPRATROPIUM
FENOFIBRATE vs FENTANYL